These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31338630)

  • 1. Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire.
    Harrington M; Hareendran A; Skalicky A; Wilson H; Clark M; Mikl J
    J Patient Rep Outcomes; 2019 Jul; 3(1):44. PubMed ID: 31338630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the Impact of Juvenile Metachromatic Leukodystrophy on Physical Activities scale.
    Brown TM; Martin S; Fehnel SE; Deal LS
    J Patient Rep Outcomes; 2017; 2(1):15. PubMed ID: 29757307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international study of caregiver-reported burden and quality of life in metachromatic leukodystrophy.
    Sevin C; Barth M; Wilds A; Afriyie A; Walz M; Dillon A; Howie K; Pang F
    Orphanet J Rare Dis; 2022 Sep; 17(1):329. PubMed ID: 36056437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: A survey-based study.
    Koto Y; Narita A; Noto S; Okada M; Ono M; Baba T; Sagara R; Sakai N
    Mol Genet Metab Rep; 2023 Sep; 36():100994. PubMed ID: 37576570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of disease in metachromatic leukodystrophy: results of a caregiver survey in the UK and Republic of Ireland.
    Thomas S; Morrison A; Morton G; Roberts P; Clark V; Imrie J
    Orphanet J Rare Dis; 2024 Feb; 19(1):87. PubMed ID: 38403596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers.
    Harrington M; Whalley D; Twiss J; Rushton R; Martin S; Huynh L; Yang H
    Orphanet J Rare Dis; 2019 Apr; 14(1):89. PubMed ID: 31036045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous development of the Pediatric GERD Caregiver Impact Questionnaire (PGCIQ) in American English and American Spanish.
    Kim J; Keininger DL; Becker S; Crawley JA
    Health Qual Life Outcomes; 2005 Jan; 3():5. PubMed ID: 15651991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA.
    Wijburg FA; Aiach K; Chakrapani A; Eisengart JB; Giugliani R; Héron B; Muschol N; O'Neill C; Olivier S; Parker S
    Mol Genet Metab; 2022 Feb; 135(2):133-142. PubMed ID: 34991944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII - a European caregiver survey.
    Morrison A; Oussoren E; Friedel T; Cruz J; Yilmaz N
    Orphanet J Rare Dis; 2019 Nov; 14(1):254. PubMed ID: 31727109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of lysosomal storage diseases in The Netherlands.
    Poorthuis BJ; Wevers RA; Kleijer WJ; Groener JE; de Jong JG; van Weely S; Niezen-Koning KE; van Diggelen OP
    Hum Genet; 1999; 105(1-2):151-6. PubMed ID: 10480370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures.
    Turner-Bowker DM; An Haack K; Krohe M; Yaworsky A; Vivas N; Kelly M; Chatterjee G; Chaston E; Mann E; Reaney M
    J Patient Rep Outcomes; 2020 Oct; 4(1):80. PubMed ID: 33000327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome.
    Nabbout R; Auvin S; Chiron C; Irwin J; Mistry A; Bonner N; Williamson N; Bennett B
    Epilepsy Behav; 2018 Jan; 78():232-242. PubMed ID: 29108913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials.
    Aldhouse NVJ; Kitchen H; Johnson C; Marshall C; Pegram H; Pease S; Collins S; Baker CL; Beaverson K; Crews C; Massey J; Wyrwich KW
    Orphanet J Rare Dis; 2022 May; 17(1):182. PubMed ID: 35525989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS).
    Mattera M; Vernon MK; Raluy-Callado M; Mikl J
    Health Qual Life Outcomes; 2018 Nov; 16(1):209. PubMed ID: 30409228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative.
    Collin-Histed T; Stoodley M; Beusterien K; Elstein D; Jaffe DH; Revel-Vilk S; Davies EH;
    Orphanet J Rare Dis; 2023 Jul; 18(1):195. PubMed ID: 37480076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Conceptual Model of Angelman Syndrome and Review of Relevant Clinical Outcomes Assessments (COAs).
    Grieco JC; Romero B; Flood E; Cabo R; Visootsak J
    Patient; 2019 Feb; 12(1):97-112. PubMed ID: 29987743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for lysosomal storage disorders.
    Meikle PJ; Grasby DJ; Dean CJ; Lang DL; Bockmann M; Whittle AM; Fietz MJ; Simonsen H; Fuller M; Brooks DA; Hopwood JJ
    Mol Genet Metab; 2006 Aug; 88(4):307-14. PubMed ID: 16600651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA).
    Hemsley KM; Hopwood JJ
    Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.